U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020832) titled 'A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation' on June 06.
Brief Summary: A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULTS AT HIGH RISK OF DELAYED GRAFT FUNCTION (DGF) FOLLOWING KIDNEY ALLOGRAFT TRANSPLANTATION
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Delayed Graft Function
End Stage Renal Disease
Deceased Donor Kidney Transplant
Intervention:
DRUG: Pegcetacoplan
Complement (C3) Inhibitor
OTHER: Placebo
Sterile solution of equal volume to active arm...